Skip to content

Clinical trials

Terminated Phase 2 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Status: Terminated Clear all

211 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20027
20034
20048
20056
20069
200714
200811
200911
20109
201116
201211
201311
20145
201510
201612
20174
20189
201912
202011
20219
20227
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated211

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
M.D. Anderson Cancer Center6
Duke University5
OHSU Knight Cancer Institute5
The Methodist Hospital Research Institute5
University of Wisconsin, Madison5
Rutgers, The State University of New Jersey4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
University of Washington4
Weill Medical College of Cornell University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms211
Neoplasm Metastasis16
Neoplasms11
Breast Neoplasms5
Ovarian Neoplasms5
Colorectal Neoplasms4
Urinary Bladder Neoplasms4
Esophageal Neoplasms3
Genital Neoplasms, Male3
Kidney Neoplasms3

Trials

Showing 1 to 25 of 211. Each trial links to its page on Pharma Observatory.

111 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.